MARKET WIRECNBC • 2h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why LUCY Stock dropped -3.43% Today — RQD Quant Desk Flash
$0.83 -3.43% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $0.82
Innovative Eyewear Inc. (LUCY) carries a Roarable Rating of D- (Sell) with 42/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D- • SELL / AVOID
Cap $7.2M
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $0.82 (-0.81%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 6/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (42/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.0% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERSELL / AVOID • D-
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D- · Rk D
Each axis scored 0–20
12M PRICE TARGET CONE-7.2% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for LUCY)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (42/100 Composite)
🔍 WHY LUCY SCORES 42/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+12/20 pts (29% of score)
20D Institutional Volume Accumulation (±12.5% realized swing band)
▲ #2 Bullish Driver: SEC 10-K Forensic Risk+11/20 pts (26% of score)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)
Disciplined Float (+0.72% YoY Shares) & executive Form 4 sales trim 15 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade C-$0.90-12.2% Next Q
50
Q2 (-2Q)Grade D$0.79+10.1% Next Q
47
Q3 (-1Q)Grade D$0.87-4.6% Next Q
45
CurrentGrade D-$0.83-7% Hist 90D α
42
Trajectory: C- (50) → D- (42)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a LUCY Turnaround Squeeze
While LUCY currently carries a cautious 42/100 (D-) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($0.89) and Max Pain ($0.87) forces dealer call-delta covering toward $2.12.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $LUCY• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “LUCY Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why LUCY Stock dropped -3.43% Today — RQD Quant Desk Flash
Innovative Eyewear Inc. (LUCY) dropped -3.43% to $0.83, trading at 13% of its 52-week range ($0.65 – $2.02). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 13% of its 52-week range ($0.65 – $2.02) with RSI-14 at 46 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $0.83 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 21.3% gross margin and $0 annual free cash flow.
Live LUCY Headlines & Catalysts
MARKET WIRECNBC • 3h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 4h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 5h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 6h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 7h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 7h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
MARKET WIREReuters • 7h ago
German ministers pledge tough action after rioters damage stores in Frankfurt - ReutersGerman ministers pledge tough action after rioters damage stores in Frankfurt Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring LUCY)
- ✓Walkthrough of LUCY's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
LUCY // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -20.95%⚡ TESTING RESISTANCE
2026-10-30O $0.83H $0.89L $0.82C $0.83VOL 47.2K
RES: $0.84SUP: $0.77SMA50: $0.89SMA200: $0.97
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
LUCY Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +62.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on LUCY today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for LUCY. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for LUCY today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (LUCY)
Health Care Rank #595 of 1016
⚔️ RXST vs LUCY Full Matrix →
1. Head-to-Head Health Care Peer Comparison (LUCY vs. RXST, STAA, EYE, WRBY)
Industry: Ophthalmic Goods (8 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Innovative Eyewear Inc. (LUCY) ranks #595 by composite RQD confidence (42/100, grade D-) and #920 by equity capitalization ($7.2M). Within this direct 5-issuer industry benchmark cohort, EYE leads on earnings valuation at 44.4x trailing P/E, while EYE leads on capital efficiency and profitability with 4.4% ROIC and — gross margin. EYE currently holds the highest overall quantitative score in the immediate peer group at 68/100 (C+) compared with LUCY at 42/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| LUCY
ACTIVE
Innovative Eyewear Inc. | D- | 42/100 | — | 21.3% | -35.0% | -3.43% | $7.2M | Benchmark Subject |
| RXST RxSight Inc. | D- | 35/100 | — | 76.6% | -14.9% | +3.06% | $210.0M | /rxst-vs-lucy → |
| STAA STAAR Surgical Company | D- | 38/100 | — | 76.2% | -35.0% | +2.56% | $1.27B | /staa-vs-lucy → |
| EYE National Vision Holdings Inc. | C+ | 68/100 | 44.4x | — | 4.4% | +7.63% | $1.32B | /eye-vs-lucy → |
| WRBY Warby Parker Inc. | D+ | 52/100 | — | 54.0% | -1.7% | +0.66% | $3.04B | /wrby-vs-lucy → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001808377In its most recent audited fiscal period (FY2025, filed 2025-12-31), Innovative Eyewear Inc. (LUCY) reported GAAP revenue of $2.7M (+62.6% vs. FY2024 revenue of $1.6M , and +131.0% cumulative change since FY2023) , GAAP net income of -$7.6M, operating cash flow of -$7.3M, and free cash flow of -$7.3M (-8.0% YoY). On the balance sheet, LUCY closed FY2025 with $10.1M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $2.7M | -$7.6M | -$7.3M | -$7.3M | $10.1M | — |
| FY2024 (FY) | 2024-12-31 | $1.6M | -$7.8M | -$6.7M | -$6.8M | $9.8M | — |
| FY2023 (FY) | 2023-12-31 | $1.2M | -$6.7M | -$5.8M | -$5.8M | — | — |
3. LUCY Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs LUCY stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Innovative Eyewear Inc. (NASDAQ: LUCY) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 42/100 at a spot price of $0.83 (-3.43% 1D, market cap $7.2M). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, LUCY ranks #595 in composite RQD confidence.
How does LUCY compare to RXST and STAA in the Health Care sector?
Within the Health Care sector (Ophthalmic Goods), LUCY carries a Roarable D- (42/100 RQD), trailing P/E of N/A, gross margin of 21.3%, and ROIC of -35.0%. By comparison, RXST (RxSight Inc.) holds a D- grade (35/100 RQD, P/E N/A, ROIC -14.9%, cap $210.0M) and STAA (STAAR Surgical Company) posts a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $1.27B). Among the 5-stock peer group, EYE leads on earnings multiple (44.4x) while EYE leads on capital efficiency (4.4% ROIC).
What are the biggest fundamental strengths and SEC risk factors for LUCY?
Per LUCY's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001808377), Innovative Eyewear Inc. generated $2.7M in revenue (+62.6% YoY), -$7.6M in net income, and -$7.3M in free cash flow against $10.1M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is LUCY trading relative to its 50-day, 200-day, and 52-week technical levels?
LUCY last traded at $0.83 (-3.43% on volume of 201,409 shares), positioning the stock -6.74% below its 50-day simple moving average ($0.89) and -14.43% below its 200-day simple moving average ($0.97). Across its 52-week range of $0.65 to $2.02, LUCY sits at the 13.1% percentile with a 14-day RSI of 46.0 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.00 to $0.93).
LUCY Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is LUCY stock moving today?
Why LUCY Stock dropped -3.43% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.